RSVPed Team

The RSVPed Team is led by Johns Hopkins Bloomberg School of Public Health Professor and CIR Director Dr. Ruth A. Karron.  The team conducts investigational vaccine research trials for childhood illnesses like RSV in infants and children.  They also conduct respiratory virus surveillance in some of their study participants. Learn more about the the diseases they study by clicking on the link below.



Respiratory syncytial virus (RSV) is the most important global cause of viral acute lower respiratory tract illness (ALRI) in infants and children. In the United States, approximately 150,000 infants are hospitalized each year with RSV pneumonia or bronchiolitis (inflammation of the small airways), and up to 2 million children under the age of 5 receive medical care for RSV infection. Globally, RSV is estimated to cause up to 34 million cases of ALRI and up to 234,000 deaths in children each year.